国际放射医学核医学杂志
國際放射醫學覈醫學雜誌
국제방사의학핵의학잡지
INTERNATIONAL JOURNAL OF RADIATION MEDICINE AND NUCLEAR MEDICINE
2013年
2期
112-115
,共4页
辐射耐受性%组蛋白去乙酰酶阻滞剂
輻射耐受性%組蛋白去乙酰酶阻滯劑
복사내수성%조단백거을선매조체제
Radiation tolerance%Histone deacetylase inhibitors
放射治疗是肿瘤的重要治疗手段之一,辐射可以导致细胞DNA双链断裂.细胞主要通过同源重组修复和非同源末端连接修复方式修复DNA双链断裂.随着对双链DNA损伤修复机制认识的深化,组蛋白去乙酰酶(HDAC)阻滞剂成为提高放射敏感性的一种新策略.HDAC可分为4类.HDAC阻滞剂可非特异性地或特异性地阻滞这4类HDAC,使组蛋白乙酰化水平提高,染色体解螺旋,核小体结构改变.一方面使DNA更易受到辐射的影响;另一方面通过降低E2F1转录因子活性抑制损伤修复蛋白Ku80、Rad51等的表达,使其不能募集DNA损伤修复蛋白,且不能形成相应的蛋白复合物,使同源重组修复和非同源末端连接修复作用延缓,在伴有或不伴有肿瘤细胞凋亡增加的情况下,提高放射敏感性.现已有一些临床试验在进行中,并取得了初步的结果.
放射治療是腫瘤的重要治療手段之一,輻射可以導緻細胞DNA雙鏈斷裂.細胞主要通過同源重組脩複和非同源末耑連接脩複方式脩複DNA雙鏈斷裂.隨著對雙鏈DNA損傷脩複機製認識的深化,組蛋白去乙酰酶(HDAC)阻滯劑成為提高放射敏感性的一種新策略.HDAC可分為4類.HDAC阻滯劑可非特異性地或特異性地阻滯這4類HDAC,使組蛋白乙酰化水平提高,染色體解螺鏇,覈小體結構改變.一方麵使DNA更易受到輻射的影響;另一方麵通過降低E2F1轉錄因子活性抑製損傷脩複蛋白Ku80、Rad51等的錶達,使其不能募集DNA損傷脩複蛋白,且不能形成相應的蛋白複閤物,使同源重組脩複和非同源末耑連接脩複作用延緩,在伴有或不伴有腫瘤細胞凋亡增加的情況下,提高放射敏感性.現已有一些臨床試驗在進行中,併取得瞭初步的結果.
방사치료시종류적중요치료수단지일,복사가이도치세포DNA쌍련단렬.세포주요통과동원중조수복화비동원말단련접수복방식수복DNA쌍련단렬.수착대쌍련DNA손상수복궤제인식적심화,조단백거을선매(HDAC)조체제성위제고방사민감성적일충신책략.HDAC가분위4류.HDAC조체제가비특이성지혹특이성지조체저4류HDAC,사조단백을선화수평제고,염색체해라선,핵소체결구개변.일방면사DNA경역수도복사적영향;령일방면통과강저E2F1전록인자활성억제손상수복단백Ku80、Rad51등적표체,사기불능모집DNA손상수복단백,차불능형성상응적단백복합물,사동원중조수복화비동원말단련접수복작용연완,재반유혹불반유종류세포조망증가적정황하,제고방사민감성.현이유일사림상시험재진행중,병취득료초보적결과.
Radiotherapy is an essential part of cancer treatment,which leads to DNA double strains break.Homogeneous recombination and heterogeneous end conjunction are the main ways which can repair DNA double strains break in the cells.It is a novel strategy,which as recognize as the mechanism of damage to DNA strains,that radiosensitivity is enhanced by histone deacetylase (HDAC)inhibitor.HDAC inhibitor is able to antagonize specifically or nonspecifically HDAC whom is forming as four various sorts,as a consequence enhancing level of histone deacetylase,decoilization of chromosome and alternation on molecular structure of nucleolus.Firstly DNA is simply influenced by radioactivity due to HDAC inhibitor,and then HDAC inhibitor effects on decline activity of E2F1 transcript factors,which cause directly expressional inhibition on the repair proteins including Ku80,Rad51,thus the molecules are unable to recruited and polymerized into correspond protein compound,as a result of HDAC inhibitor the function of homogeneous recombination and heterogeneous end conjunction becomes minimized.As the circumstances are shown involving augment or non-augment of apoptosis among cancer cells,HDAC inhibitor enhance the radiosensitivity eventually,which has been applicated into clinical trials and obtain primary achievement.